​

Funding Round

Post-IPO Equity - Olema Oncology

Post-IPO Equity - Olema Oncology

Investment Firm

Overview

Olema Oncology is a preclinical biotechnology company that develops new drugs for the treatment and prevention of breast cancer.

Announced Date

Sep 05, 2023

Funding Type

Post Ipo Equity

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Paradigm BioCapital Advisors

Paradigm BioCapital Advisors

Paradigm BioCapital Advisors is a late_stage_venture firm.

Participant Investors

8

Investor Name
Participant InvestorLogos Capital
Participant InvestorBiotechnology Value Fund
Participant InvestorDeep Track Capital
Participant InvestorLightspeed Venture Partners
Participant InvestorVivo Capital

Round Details and Background

Olema Oncology raised $130000000 on 2023-09-05 in Post-IPO Equity

Olema Oncology is a preclinical biotechnology company that develops new drugs for the treatment and prevention of breast cancer.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 01, 2020
Series C - Olema Oncology
14-85.0M
Sep 05, 2023
Post-IPO Equity - Olema Oncology
8-130.0M
Sep 05, 2023
Post-IPO Debt - Olema Oncology
1-50.0M
Sep 13, 2023
Post-IPO Equity - Olema Oncology
-130.0M

Recent Activity

There is no recent news or activity for this profile.